Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine
- PMID: 28242537
- PMCID: PMC5545131
- DOI: 10.1016/j.drugalcdep.2016.12.025
Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine
Abstract
Background: Ukraine's HIV epidemic is concentrated among people who inject drugs (PWID), however, coverage with opioid agonist therapies (OATs) available mostly at specialty addiction clinics is extremely low. OAT integrated into primary healthcare clinics (PHCs) provides an opportunity for integrating comprehensive healthcare services and scaling up OAT.
Methods: A pilot study of PHC-based integrated care for drug users conducted in two Ukrainian cities between 2014 and 2016 included three sub-studies: 1) cross-sectional treatment site preference assessment among current OAT patients (N=755); 2) observational cohort of 107 PWID who continued the standard of care versus transition of stabilized and newly enrolled PWID into PHC-based integrated care; and 3) pre/post analysis of attitudes toward PWID and HIV patients by PHC staff (N=26).
Results: Among 755 OAT patients, 53.5% preferred receiving OAT at PHCs, which was independently correlated with convenience, trust in physician, and treatment with methadone (vs. buprenorphine). In 107 PWID observed over 6 months, retention in treatment was high: 89% in PWID continuing OAT in specialty addiction treatment settings (standard of care) vs 94% in PWID transitioning to PHCs; and 80% among PWID newly initiating OAT in PHCs. Overall, satisfaction with treatment, subjective self-perception of well-being, and trust in physician significantly increased in patients prescribed OAT in PHCs. Among PHC staff, attitudes towards PWID and HIV patients significantly improved over time.
Conclusions: OAT can be successfully integrated into primary care in low and middle-income countries and improves outcomes in both patients and clinicians while potentially scaling-up OAT for PWID.
Keywords: HIV/AIDS; Integrated care; Methadone; Patient preferences; Primary care; Retention; Ukraine.
Copyright © 2017 Elsevier B.V. All rights reserved.
Conflict of interest statement
None.
Figures
Similar articles
-
The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.Addiction. 2021 Jan;116(1):83-93. doi: 10.1111/add.15115. Epub 2020 Aug 9. Addiction. 2021. PMID: 32428276 Free PMC article.
-
Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: implications for retention on opioid agonist therapy.J Int AIDS Soc. 2016 Jul 18;19(4 Suppl 3):20897. doi: 10.7448/IAS.19.4.20897. eCollection 2016. J Int AIDS Soc. 2016. PMID: 27435717 Free PMC article.
-
Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine.Contemp Clin Trials. 2024 Nov;146:107690. doi: 10.1016/j.cct.2024.107690. Epub 2024 Sep 14. Contemp Clin Trials. 2024. PMID: 39265780 Clinical Trial.
-
What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.Int J Drug Policy. 2014 Jan;25(1):53-60. doi: 10.1016/j.drugpo.2013.08.004. Epub 2013 Sep 4. Int J Drug Policy. 2014. PMID: 24113623 Review.
-
Initial strategies for integrating buprenorphine into HIV care settings in the United States.Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6. doi: 10.1086/508183. Clin Infect Dis. 2006. PMID: 17109306 Review.
Cited by
-
The development and initial validation of the Russian version of the BASIS-24.Addict Sci Clin Pract. 2022 Nov 26;17(1):65. doi: 10.1186/s13722-022-00343-0. Addict Sci Clin Pract. 2022. PMID: 36435811 Free PMC article. Review.
-
Preliminary analysis of self-reported quality health indicators of patients on opioid agonist therapy at specialty and primary care clinics in Ukraine: A randomized control trial.PLOS Glob Public Health. 2022 Nov 2;2(11):e0000344. doi: 10.1371/journal.pgph.0000344. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962514 Free PMC article.
-
Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.J Int AIDS Soc. 2024 Feb;27(2):e26202. doi: 10.1002/jia2.26202. J Int AIDS Soc. 2024. PMID: 38379179 Free PMC article. Clinical Trial.
-
Responding to health policy recommendations on managing opioid use disorder during Russia's invasion of Ukraine: Divergent responses from the frontline to the west.Front Public Health. 2023 Jan 13;10:1044677. doi: 10.3389/fpubh.2022.1044677. eCollection 2022. Front Public Health. 2023. PMID: 36711398 Free PMC article.
-
Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan.Can Fam Physician. 2024 Apr;70(4):e52-e60. doi: 10.46747/cfp.7004e52. Can Fam Physician. 2024. PMID: 38626996 Free PMC article.
References
-
- Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R Collaborative B. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J. Acquir. Immune Defic. Syndr. 2011;56(Suppl. 1): S22–S32. - PMC - PubMed
-
- Alwin DF. Feeling thermometers versus 7-point scales – which are better? Soc. Method Res. 1997;25:318–340.
-
- Anderson LA, Dedrick RF. Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol. Rep. 1990;67:1091–1100. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical